Trial Profile
Assessment of Staccato Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2021
Price :
$35
*
At a glance
- Drugs Alprazolam (Primary)
- Indications Reflex epilepsy
- Focus Proof of concept; Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 03 Jul 2019 Results published in the Epilepsia
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology.
- 30 Jan 2017 Status changed from recruiting to completed.